Tech Company Financing Transactions

Receptos Funding Round

On 11/23/2009, Receptos raised $25 million in Series A investment from Arch Venture Partners, Flagship Pioneering and Lilly Ventures.

Transaction Overview

Company Name
Receptos
Announced On
11/23/2009
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors

Arch Venture Partners (Robert Nelsen)

Flagship Pioneering (Douglas Cole)

Lilly Ventures (Edward Torres)

Venrock (William Rastetter)

Proceeds Purpose
The Series A capital will support the company's lead sphingosine-1-phosphate receptor 1 (S1P1) clinical candidate through Phase 1 human clinical trials, development of a second IND candidate, as well as the select partnering of the proprietary technology platform for GPCR drug discovery and development.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10835 Road to the Cure 205
San Diego, CA 92121
USA
Phone
(858) 652-5700
Website
www.receptos.com
Email Address
[email protected]
Overview
Receptos is developing the next generation in GPCR drug discovery.
Profile
Receptos LinkedIn Company Profile
Social Media
Receptos Company Twitter Account
Company News
Receptos News
Facebook
Receptos on Facebook
YouTube
Receptos on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Faheem Hasnain
  Faheem Hasnain LinkedIn Profile  Faheem Hasnain Twitter Account  Faheem Hasnain News  Faheem Hasnain on Facebook
Chief Medical Officer
Sheila Gujrathi
  Sheila Gujrathi LinkedIn Profile  Sheila Gujrathi Twitter Account  Sheila Gujrathi News  Sheila Gujrathi on Facebook
Chief Scientific Officer
Robert Peach
  Robert Peach LinkedIn Profile  Robert Peach Twitter Account  Robert Peach News  Robert Peach on Facebook
Chief Technical Officer
Marcus Boehm
  Marcus Boehm LinkedIn Profile  Marcus Boehm Twitter Account  Marcus Boehm News  Marcus Boehm on Facebook
VP - Bus. Development
Chrysa Mineo
  Chrysa Mineo LinkedIn Profile  Chrysa Mineo Twitter Account  Chrysa Mineo News  Chrysa Mineo on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/19/2009: MyFit venture capital transaction
Next: 11/23/2009: ReaMetrix venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.